Accumulated genetic evidence suggests that BAP1 could be a tumour suppressor because the BAP1 gene is ubiquitously mutated in mesothelioma, uveal melanoma, melanocytic tumour, renal cell carcinoma and other cancers31, 34. This evidence concerns the gene BAP1 and hereditary clear cell renal cell carcinoma.